Source link : https://newshealth.biz/health-news/long-acting-hiv-drug-switch-shows-no-major-metabolic-impact/
In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks. Medscape Medical News Source link : https://www.medscape.com/viewarticle/long-acting-hiv-drug-switch-shows-no-major-metabolic-impact-2026a10005vf?src=rss Author : Publish date : 2026-02-25 04:53:00 Copyright for syndicated content belongs to the linked Source.
The post Long-Acting HIV Drug Switch Shows No Major Metabolic Impact first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-25 04:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8